Older GLP-1 medications show minimal risk Liraglutide, dulaglutide, and exenatide did not show statistically significant increases in hair loss reports
Many report noticeable changes within 24 weeks, depending on individual health conditions, lifestyle, and recovery demands
Retrieved November 9, 2021 from Urbanski, G., Hamel, J.-F., Prouveur, B., Annweiler, C., Ghali, A., Cassereau, J., et al
While uncommon, some individuals may experience slight swelling, redness, or temporary changes in pigmentation
Designing formulation compositions for high-concentration biotherapeutics currently relies on empirically screening for solution conditions and excipients that optimize the stability and viscosity of a given molecule of interest
Hartman NR, Cysyk RL, Bruneau-Wack C, Thenot JP, Parker RJ, Strong JM